Treatment strategy and perioperative risk in patients with idiopathic thrombocytopenic purpura undergoing cardiac surgery

Thoracic and Cardiovascular Surgeon

Volumn 49, Issue 5, 2001, Pages 316-317

  Christiansen, S ^a   Redmann, K ^a   Schmid, C ^a   Scheld, H H ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cardiac surgery; Idiopathic thrombocytopenic purpura; Immunoglobulin treatment; Perioperative risk

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN 7S; VENIMMUN N;

ADULT; AGED; ARTICLE; BLEEDING; CASE REPORT; DOSE RESPONSE; EXTRACORPOREAL CIRCULATION; FEMALE; HEART SURGERY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; PERIOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SPLENECTOMY; SURGICAL RISK; THROMBOCYTE TRANSFUSION;

AGED; CARDIAC SURGICAL PROCEDURES; EXTRACORPOREAL CIRCULATION; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; LENGTH OF STAY; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PLATELET COUNT; PREOPERATIVE CARE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RISK FACTORS;

EID: 0034753772     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17804     Document Type: Article

References (6)

1. Preoperative immunoglobulin treatment in patients with Werlhof's disease undergoing cardiac operation
2. Are patients with Werlhof's disease at increased risk for bleeding complications when undergoing cardiac surgery?
3. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
4. Early release following cardiac surgery
5. Coronary artery bypass grafting in immune thrombocytopenic purpura
6. Autoantibodies Against Platelet Glycoproteins in Autoimmune Thrombocytopenic Purpura: Their Clinical Significance and Response to Treatment